Levothyroxine and Calcium Separation Time: 4 Hours

Tirosint is a brand of levothyroxine sodium delivered as a liquid-filled gel capsule (made by IBSA), used to treat hypothyroidism and, at suppressive doses, to manage differentiated thyroid cancer. It is FDA-approved for these indications. Calcium supplements and calcium-containing antacids can reduce how much levothyroxine your gut absorbs, and this holds true for Tirosint as well as for standard tablets. The fix is not avoidance but timing: taking Tirosint and calcium at least 4 hours apart is the standard approach recommended in thyroid treatment guidelines, and a follow-up TSH check 6 to 8 weeks after any change in your calcium routine is how you confirm the timing is working.
At a glance
- Interaction type / Pharmacokinetic (reduced absorption), not a pharmacodynamic drug interaction
- Mechanism / Calcium ions bind (chelate) levothyroxine in the small intestine, forming a complex the gut cannot absorb well
- Calcium carbonate vs. citrate / Both interfere; carbonate depends on stomach acid, citrate does not, but neither is established as safe to co-administer
- Recommended separation window / At least 4 hours between Tirosint and any calcium source, per American Thyroid Association guidance
- Monitoring interval / TSH recheck roughly 6 to 8 weeks after any meaningful change in calcium timing or dose
- Tirosint-specific claim / The gel-cap formulation improves dissolution consistency but does not prevent calcium-related chelation, since that happens further down the gut
- Target TSH / Commonly 0.5 to 2.5 mIU/L for standard replacement; lower targets apply for some thyroid cancer patients, set individually by an oncologist or endocrinologist
Why calcium interferes with levothyroxine absorption
Levothyroxine is absorbed mainly in the jejunum and ileum, with most absorption occurring within the first few hours after a dose. Calcium ions, whether from a supplement, an antacid, or a calcium-rich meal, can bind to levothyroxine in the intestinal lumen and form a complex that is poorly absorbed. This is a physical, pharmacokinetic interaction, not a change in how the drug behaves once it reaches the bloodstream.
A controlled study by Singh and colleagues, published in JAMA, evaluated the effect of calcium carbonate on levothyroxine absorption and found a measurable reduction in absorption when the two were taken together. [5] A separate short report by Butner and colleagues described a patient who developed biochemical hypothyroidism after starting calcium carbonate alongside levothyroxine, with improvement after separating the doses. [1] Together with case reports such as one published in JAMA describing similar clinical hypothyroidism after calcium initiation, [4] this evidence supports a real, clinically relevant interaction. It does not, on its own, establish one precise percentage of absorption loss that applies to every patient, every calcium dose, and every formulation. Published estimates for calcium's effect on levothyroxine absorption commonly fall in a range of roughly 20 to 40 percent depending on calcium dose and form; treat that as a working estimate to explain the size of the problem, not as a number that predicts your individual result.
Does the gel-cap formulation change anything?
Tirosint was developed to reduce absorption variability tied to stomach acid and tablet dissolution, which can matter for patients with achlorhydria, inflammatory bowel disease, or a history of bariatric surgery. A pharmacokinetic review of levothyroxine formulations discusses evidence that Tirosint can produce more consistent blood levels than standard tablets under fasting conditions in some populations. [2] That advantage addresses dissolution in the stomach. Calcium's interference happens afterward, in the small intestine, where free calcium ions are present regardless of how the levothyroxine capsule dissolved. There is no evidence that Tirosint's formulation blocks or meaningfully reduces the calcium-chelation effect. The 4-hour separation guidance applies to Tirosint the same way it applies to conventional tablets.
Calcium carbonate versus calcium citrate
Calcium carbonate requires stomach acid to dissolve, so it is most likely to be affected by, and to affect, other pH-dependent processes. Calcium citrate dissolves without needing stomach acid. Both forms still release free calcium ions in the gut, and both have been associated with reduced levothyroxine absorption in the literature. [3] There is no controlled trial establishing that calcium citrate is safe to take at the same time as levothyroxine; the safer approach is to apply the same 4-hour separation to either form.
What a reduced absorption day actually means
If calcium taken simultaneously with your levothyroxine meaningfully cuts absorption for that dose, the practical effect is similar to skipping a portion of your prescribed dose that day. A single accidental overlap is unlikely to cause lasting harm. A pattern of repeated overlap, over weeks, can produce a slow rise in TSH and the return of hypothyroid symptoms: fatigue, weight gain, cold intolerance, dry skin, or a foggy feeling. Patients on tight suppressive targets after thyroid cancer treatment have less room for this kind of drift and may need more careful timing.
The 4-hour separation rule and how to apply it
The American Thyroid Association's 2014 guidance on treating hypothyroidism addresses spacing levothyroxine from substances known to impair its absorption, including calcium carbonate, and supports separating the two by a period of hours rather than taking them together. [6] The exact wording of the guideline should be checked against the primary document before it is quoted directly in patient materials; what is well established across the literature is the practical recommendation itself, a minimum separation of about 4 hours.
Three practical schedules cover most situations:
Morning Tirosint, evening calcium. Take Tirosint on an empty stomach 30 to 60 minutes before breakfast. Take your calcium supplement with dinner or at bedtime.
Bedtime Tirosint, midday calcium. Some patients prefer taking levothyroxine at bedtime, at least 2 hours after their last meal. In that case, calcium can move to lunchtime. This is an accepted alternative dosing pattern, though switching your usual timing is worth discussing with your prescriber rather than changing on your own.
Split calcium doses. If your calcium regimen is twice daily, anchor Tirosint in the morning and keep both calcium doses at least 4 hours away from it, for example at lunch and dinner.
Dietary calcium counts too, though its effect is generally smaller than a dedicated supplement. A glass of milk contains roughly 300 mg of calcium. Taking Tirosint well before breakfast, rather than with a calcium-containing meal, avoids most of this overlap.
Evidence-status interaction assessment: calcium and Tirosint
Use this to separate what the evidence actually supports from what is reasonable extrapolation, and to know what still needs a clinician's or pharmacist's confirmation.
| Status | What it means here | Example from this interaction |
|---|---|---|
| Established | Supported by controlled studies or consistent case evidence, and reflected in guideline-level recommendations | Calcium reduces levothyroxine absorption through intestinal chelation; separating doses by hours restores absorption in reported cases [1] [4] [5] |
| Plausible but not directly tested for this formulation | Mechanistically expected based on how the drug and interacting substance behave, but not confirmed with Tirosint-specific trial data | That Tirosint's improved dissolution does not prevent calcium chelation, since chelation occurs after dissolution |
| Not established | No controlled data identified that supports the specific magnitude or claim as stated | An exact percentage of absorption loss that applies broadly across patients, doses, and calcium forms; a formal trial testing calcium citrate timed simultaneously with Tirosint |
| Needs verification with your clinician or pharmacist | Depends on your specific regimen, other medications, and lab trend | Whether your specific calcium dose and product require more than a 4-hour gap; whether a PPI, iron supplement, or bisphosphonate you also take changes the recommended schedule; your personal TSH target |
Monitoring TSH when you take both
Starting, stopping, or changing calcium is a meaningful event from your thyroid dose's perspective, even if your Tirosint prescription has not changed. Tell your prescribing clinician about any new calcium supplement, dose change, or switch between calcium carbonate and calcium citrate.
A TSH recheck roughly 6 to 8 weeks after such a change is standard practice, since it takes that long for TSH to settle at a new steady state. [6] Reasonable times to ask for a repeat TSH include:
- Starting a calcium supplement while already stable on Tirosint
- Stopping calcium after months of combined use
- Switching calcium forms
- Changing calcium dose by 500 mg or more
Target TSH for most adults on levothyroxine replacement runs about 0.5 to 2.5 mIU/L, though this is individualized. [6] Patients on suppressive therapy for thyroid cancer often have a lower, individualized target set by their treating oncologist or endocrinologist. If your TSH rises above your personal target after a calcium change, that is useful diagnostic information, not necessarily a sign your Tirosint dose is wrong.
Special situations that raise the stakes
Malabsorption conditions. Tirosint is often chosen for patients with celiac disease, short bowel syndrome, or post-bariatric anatomy, precisely because standard tablets can absorb unpredictably in these conditions. These same patients frequently need higher-dose calcium for bone health. When baseline absorption is already compromised, getting the calcium-Tirosint timing right matters more, not less.
Osteoporosis treatment with bisphosphonates. Bisphosphonates such as alendronate or risedronate also require an empty stomach and their own separation from calcium and other supplements. Patients managing both hypothyroidism and osteoporosis are often juggling three timing requirements at once: Tirosint on waking, a bisphosphonate 30 to 60 minutes later on the same empty stomach (per that drug's own label instructions), and calcium moved to evening. This is worth mapping out explicitly with your clinician or pharmacist rather than approximating it.
Pregnancy. Thyroid hormone requirements rise during pregnancy, and absorption interference has higher stakes when replacement needs are already increasing. Pregnant patients on Tirosint who are also taking prenatal calcium or prenatal vitamins with calcium should confirm their timing plan with their obstetric and endocrine team. [6]
Other supplements and drugs that interfere the same way
The chelation and acid-dependency mechanisms behind the calcium interaction apply to several other common substances. A minimum 4-hour separation from Tirosint is a reasonable general rule for:
- Iron supplements. A controlled study by Campbell and colleagues, published in Annals of Internal Medicine, found that ferrous sulfate taken simultaneously with levothyroxine reduced its effectiveness, an effect attributed to a similar chelation process. [8]
- Magnesium- or aluminum-containing antacids (for example, Maalox or Mylanta), which can bind levothyroxine in the gut.
- Calcium-containing antacids (for example, Tums or Rolaids), which behave the same as a dedicated calcium supplement for this purpose.
- Bile acid sequestrants such as cholestyramine or colestipol, which bind levothyroxine directly; a longer separation of 4 to 6 hours is often advised for these.
- Proton pump inhibitors, which reduce stomach acid and can affect absorption of levothyroxine formulations that depend on gastric acid for dissolution. Research on thyroxine absorption in patients with reduced gastric acid production or chronic gastritis has examined this general pathway. [9] Whether Tirosint's pH-independent dissolution meaningfully changes the practical impact of a PPI specifically has not been directly established in the sources reviewed here, so if you take a PPI, this is worth raising with your prescriber rather than assuming the gel-cap formulation resolves it.
Keep a current list of every supplement and medication you take and bring it to each visit so timing conflicts can be checked as a set, not one at a time.
Evidence boundary: what is established and what is not
Established: calcium interferes with levothyroxine absorption through intestinal chelation, this has been observed with calcium carbonate and documented in case reports and controlled studies, and separating doses by hours is the accepted mitigation reflected in thyroid treatment guidelines. [1] [4] [5] [6]
Plausible but not directly proven for Tirosint specifically: that the gel-cap formulation's dissolution advantage has no bearing on the size of the calcium interaction. This follows from where each process happens in the gut, but no trial identified here directly measured calcium's effect on Tirosint absorption compared with tablet levothyroxine.
Not established: a single precise absorption-loss percentage that applies to all patients, calcium doses, and calcium forms; that calcium citrate is meaningfully safer than calcium carbonate when taken simultaneously with levothyroxine; and any Tirosint-specific data on interaction with proton pump inhibitors.
This article does not provide an individualized dosing plan. Your own separation schedule, monitoring interval, and TSH target should be set with your prescribing clinician, who can account for your other medications, absorption history, and treatment goal.
When to contact your clinician
Reach out to your prescriber or pharmacist if:
- You started calcium or another new supplement and are noticing symptoms of low thyroid hormone
- Your TSH has moved outside your target range on a recent lab
- You are not sure your current schedule keeps Tirosint and calcium at least 4 hours apart
- You are pregnant and taking both
- You are changing calcium form or dose, or adding a PPI, iron supplement, or bisphosphonate to your regimen
Do not stop or adjust your Tirosint dose on your own. If you suspect a timing problem, fix the schedule and ask about a TSH check; your clinician can determine whether the timing alone explains the change or whether your dose needs adjustment.
Frequently asked questions
Can I take calcium while on Tirosint?
Does calcium interact with Tirosint?
How long should I wait between Tirosint and calcium?
Is calcium citrate safer than calcium carbonate with Tirosint?
Does Tirosint's gel-cap formulation protect against the calcium interaction?
What happens if I accidentally take calcium and Tirosint together?
How do I know if calcium is affecting my Tirosint levels?
Can calcium-rich foods like milk interfere with Tirosint too?
Does Tirosint interact with iron supplements the same way?
Should I tell my clinician I'm taking calcium with Tirosint?
References
-
Butner LE, Fulco PP, Feldman G. Calcium carbonate-induced hypothyroidism. Ann Intern Med. 2000;132(7):595 to 596. https://pubmed.ncbi.nlm.nih.gov/10744601/
-
Colucci P, Yue CS, Ducharme M, Benvenga S. A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur Endocrinol. 2013;9(1):40 to 47. https://pubmed.ncbi.nlm.nih.gov/29922364/
-
Zamfirescu I, Carlson HE. Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid. 2011;21(5):483 to 486. https://pubmed.ncbi.nlm.nih.gov/21470078/
-
Schneyer CR. Calcium carbonate and reduction of levothyroxine efficacy. JAMA. 1998;279(10):750. https://pubmed.ncbi.nlm.nih.gov/9508153/
-
Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000;283(21):2822 to 2825. https://pubmed.ncbi.nlm.nih.gov/10838651/
-
Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670 to 1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
-
Bauer DC, et al. Effects of calcium supplementation on bone density in postmenopausal women. Menopause. 2021;28(4):371 to 381. https://pubmed.ncbi.nlm.nih.gov/33512992/
-
Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong NC. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992;117(12):1010 to 1013. https://pubmed.ncbi.nlm.nih.gov/1443969/
-
Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354(17):1787 to 1795. https://pubmed.ncbi.nlm.nih.gov/16641395/
